FINISHED DOSAGE FORMULATIONS
Drug : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204168
Country : US
Patented : Yes
Drug : URSO FORTE
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : K-TAB
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18279
Country : US
Patented : No
Drug : URSO 250
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20616
Country : US
Patented : No
Drug : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20092
Country : US
Patented : No
ESTROGENS, CONJUGATED SYNTHETIC B
Drug : ENJUVIA
Dosage Form : TABLET; ORAL
Application Number : 21443
Country : US
Patented : No
Drug : SIROLIMUS
Dosage Form : TABLET; ORAL
Application Number : 201578
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78889
Country : US
Patented : No
Drug : ERRIN
Dosage Form : TABLET; ORAL-28
Application Number : 76225
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES